{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:51Z","timestamp":1761630471206},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.transproceed.2007.08.038","type":"journal-article","created":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T22:44:49Z","timestamp":1199918689000},"page":"2565-2567","source":"Crossref","is-referenced-by-count":9,"title":["Failure of Anti-CD20 Monoclonal Antibody Therapy to Prevent Antibody-Mediated Rejection in Three Crossmatch-Positive Renal Transplant Recipients"],"prefix":"10.1016","volume":"39","author":[{"given":"M.","family":"Matignon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tagnaouti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Audard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Grimbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2007.08.038_bib1","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.TP.0000153297.11006.13","article-title":"Antidonor antibodies and transplantation: how to deal with them before and after transplantation","volume":"79","author":"Glotz","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2007.08.038_bib2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1600-6143.2003.00180.x","article-title":"Overcoming a positive crossmatch in living-donor kidney transplantation","volume":"3","author":"Gloor","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.08.038_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.08.038_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.08.038_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ncpneph0133","article-title":"Drug insight: rituximab in renal disease and transplantation","volume":"2","author":"Salama","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.transproceed.2007.08.038_bib6","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/j.1600-6143.2006.01497.x","article-title":"Pharmacodynamics of rituximab in kidney allotransplantation","volume":"6","author":"Genberg","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2007.08.038_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0966-3274(03)00059-5","article-title":"Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys","volume":"12","author":"Schroder","year":"2003","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2007.08.038_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2007.08.038_bib9","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507009773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134507009773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T19:00:10Z","timestamp":1546369210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134507009773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0041134507009773"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2007.08.038","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}